The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review
Abstract
The role of bacterial biofilms in chronic and recalcitrant diseases is widely appreciated, and the treatment of biofilm infection is an increasingly important area of research. Chronic rhinosinusitis (CRS) is a complex disease associated with sinonasal dysbiosis and the presence of bacterial biofilms. While most biofilm-related diseases are associated with highly persistent but relatively less severe inflammation, the presence of biofilms in CRS is associated with greater severity of inflammation and recalcitrance despite appropriate treatment. Oral antibiotics are commonly used to treat CRS but they are often ineffective, due to poor penetration of the sinonasal mucosa and the inherently antibiotic resistant nature of bacteria in biofilms. Topical non-antibiotic antibiofilm agents may prove more effective, but few such agents are available for sinonasal application. We review compounds with antibiofilm activity that may be useful for treating biofilm-associated CRS, including halogen-based compounds, quaternary ammonium compounds and derivatives, biguanides, antimicrobial peptides, chelating agents and natural products. These include preparations that are currently available and those still in development. For each compound, antibiofilm efficacy, mechanism of action, and toxicity as it relates to sinonasal application are summarised. We highlight the antibiofilm agents that we believe hold the greatest promise for the treatment of biofilm-associated CRS in order to inform future research on the management of this difficult condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current topical antibacterial treatments have failed to show efficacy, due to poor residence time [62].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Severing, A.-L., Rembe, J.-D., Koester, V., & Stuermer, E. K. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky432 · Cited by 120
Research works printed but not linked: 125
- Akdis, 2021, Does the Epithelial Barrier Hypothesis Explain the Increase in Allergy, Autoimmunity and Other Chronic Conditions?, Nat. Rev. Immunol., 21, 739, 10.1038/s41577-021-00538-7 · DOI · Paper page
- Al-Bakri, 2009, The Assessment of the Antibacterial and Antifungal Activities of Aspirin, EDTA and Aspirin-EDTA Combination and Their Effectiveness as Antibiofilm Agents, J. Appl. Microbiol., 107, 280, 10.1111/j.1365-2672.2009.04205.x · DOI
- Alandejani, 2009, Effectiveness of Honey on Staphylococcus aureus and Pseudomonas aeruginosa Biofilms, Otolaryngol. Head Neck Surg., 141, 114, 10.1016/j.otohns.2009.01.005 · DOI · Paper page
- Ammons, 2013, Mini-review: Lactoferrin: a Bioinspired, Anti-biofilm Therapeutic, Biofouling, 29, 443, 10.1080/08927014.2013.773317 · DOI
- Banin, 2006, Chelator-induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm, Appl. Environ. Microbiol., 72, 2064, 10.1128/aem.72.3.2064-2069.2006 · DOI · Paper page
- Barreto, 2020, Addressing the Challenges in Antisepsis: Focus on Povidone Iodine, Int. J. Antimicrob. Agents, 56, 106064, 10.1016/j.ijantimicag.2020.106064 · DOI
- Berditsch, 2019, Supreme Activity of Gramicidin S against Resistant, Persistent and Biofilm Cells of Staphylococci and Enterococci, Sci. Rep., 9, 17938, 10.1038/s41598-019-54212-z · DOI
- Berditsch, 2015, Synergistic Effect of Membrane-Active Peptides Polymyxin B and Gramicidin S on Multidrug-Resistant Strains and Biofilms of Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 59, 5288, 10.1128/aac.00682-15 · DOI
- Bigliardi, 2017, Povidone Iodine in Wound Healing: a Review of Current Concepts and Practices, Int. J. Surg., 44, 260, 10.1016/j.ijsu.2017.06.073 · DOI · Paper page
- Birk, 2015, Polyhexanide-containing Solution Reduces Ciliary Beat Frequency of Human Nasal Epithelial Cells In Vitro, Eur. Arch. Otorhinolaryngol., 272, 377, 10.1007/s00405-014-3112-5 · DOI
- Blaskovich, 2021, The Antimicrobial Potential of Cannabidiol, Commun. Biol., 4, 7, 10.1038/s42003-020-01530-y · DOI · Paper page
- Bridier, 2011, Dynamics of the Action of Biocides in Pseudomonas aeruginosa Biofilms, Antimicrob. Agents Chemother., 55, 2648, 10.1128/aac.01760-10 · DOI
- Campanac, 2002, Interactions between Biocide Cationic Agents and Bacterial Biofilms, Antimicrob. Agents Chemother., 46, 1469, 10.1128/aac.46.5.1469-1474.2002 · DOI · Paper page
- Camplin, 2014, Manuka Honey Treatment of Biofilms of Pseudomonas aeruginosa Results in the Emergence of Isolates with Increased Honey Resistance, Ann. Clin. Microbiol. Antimicrob., 13, 19, 10.1186/1476-0711-13-19 · DOI
- Capriotti, 2018, Efficacy of Dilute Povidone-Iodine against Multi-Drug Resistant Bacterial Biofilms, Fungal Biofilms and Fungal Spores, Clin. Res. Dermatol. Open Access, 5, 1, 10.15226/2378-1726/5/1/00174 · DOI
- Cavaliere, 2014, The Biofilm Matrix Destabilizers, EDTA and DNaseI, Enhance the Susceptibility of Nontypeable Hemophilus Influenzae Biofilms to Treatment with Ampicillin and Ciprofloxacin, MicrobiologyOpen, 3, 557, 10.1002/mbo3.187 · DOI
- Chen, 2012, Bacterial Biofilms in Chronic Rhinosinusitis and Their Relationship with Inflammation Severity, Auris Nasus Larynx, 39, 169, 10.1016/j.anl.2011.04.014 · doi:10.1016/j.anl.2011.04.014
- Chennupati, 2009, Effects of an LL-37–Derived Antimicrobial Peptide in an Animal Model of Biofilm Pseudomonas Sinusitis, Am. J. Rhinol Allergy, 23, 46, 10.2500/ajra.2009.23.3261 · doi:10.2500/ajra.2009.23.3261
- Cherian, 2019, Effect of Commercial Nasal Steroid Preparation on Bacterial Growth, Int. Forum Allergy Rhinol, 9, 766, 10.1002/alr.22312 · doi:10.1002/alr.22312
- Chiu, 2008, Baby Shampoo Nasal Irrigations for the Symptomatic post–functional Endoscopic Sinus Surgery Patient, Am. J. Rhinol, 22, 34, 10.2500/ajr.2008.22.3122 · DOI · Paper page
- Cooper, 2007, Iodine Revisited, Int. Wound J., 4, 124, 10.1111/j.1742-481x.2007.00314.x · DOI
- Damour, 1992, Cytotoxicity Evaluation of Antiseptics and Antibiotics on Cultured Human Fibroblasts and Keratinocytes, Burns, 18, 479, 10.1016/0305-4179(92)90180-3 · DOI
- Daood, 2020, A Quaternary Ammonium Silane Antimicrobial Triggers Bacterial Membrane and Biofilm Destruction, Sci. Rep., 10, 10970, 10.1038/s41598-020-67616-z · DOI
- Dean, 2011, Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-Enantiomer of LL-37, Front. Microbiol., 2, 128, 10.3389/fmicb.2011.00128 · DOI · Paper page
- Drilling, 2014, Safety and Efficacy of Topical Bacteriophage and Ethylenediaminetetraacetic Acid Treatment of Staphylococcus aureus Infection in a Sheep Model of Sinusitis, Int. Forum Allergy Rhinol, 4, 176, 10.1002/alr.21270 · DOI
- Farha, 2020, Uncovering the Hidden Antibiotic Potential of Cannabis, ACS Infect. Dis., 6, 338, 10.1021/acsinfecdis.9b00419 · DOI
- Ferran, 2016, Comparison of the In Vitro Activity of Five Antimicrobial Drugs against Staphylococcus Pseudintermedius and Staphylococcus Aureus Biofilms, Front. Microbiol., 7, 1187, 10.3389/fmicb.2016.01187 · DOI
- Fokkens, 2020, European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology Suppl., 29, 1, 10.4193/rhin20.600 · DOI · Paper page
- Fong, 2019, Safety and Efficacy of a Bacteriophage Cocktail in an In Vivo Model of Pseudomonas aeruginosa Sinusitis, Transl Res., 206, 41, 10.1016/j.trsl.2018.12.002 · DOI
- Fong, 2017, Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients, Front Cel Infect Microbiol, 7, 418, 10.3389/fcimb.2017.00418 · DOI · Paper page
- Foreman, 2011, Do biofilms Contribute to the Initiation and Recalcitrance of Chronic Rhinosinusitis?, Laryngoscope, 121, 1085, 10.1002/lary.21438 · DOI
- Gaurav, 2020, Assessment of Polymyxin B–Doxycycline in Combination against Pseudomonas aeruginosa In Vitro and in a Mouse Model of Acute Pneumonia, Int. J. Antimicrob. Agents, 56, 106022, 10.1016/j.ijantimicag.2020.106022 · DOI
- Gawande, 2014, Antibiofilm Efficacy of DispersinB® Wound spray Used in Combination with a Silver Wound Dressing, Microbiol. Insights, 7, 9, 10.4137/mbi.s13914 · DOI
- Gilbert, 2005, Cationic Antiseptics: Diversity of Action under a Common Epithet, J. Appl. Microbiol., 99, 703, 10.1111/j.1365-2672.2005.02664.x · DOI · Paper page
- Graziano, 2015, Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm, PLoS ONE, 10, e0128098, 10.1371/journal.pone.0128098 · DOI
- Günther, 2021, Ability of Chlorhexidine, Octenidine, Polyhexanide and Chloroxylenol to Inhibit Metabolism of Biofilm-Forming Clinical Multidrug-Resistant Organisms, J. Infect. Prev., 22, 12, 10.1177/1757177420963829 · DOI
- Hardcastle, 2017, The In Vitro Mucolytic Effect of Xylitol and Dornase Alfa on Chronic Rhinosinusitis Mucus, Int. Forum Allergy Rhinol, 7, 889, 10.1002/alr.21970 · DOI
- Harrison, 2008, Copper and Quaternary Ammonium Cations Exert Synergistic Bactericidal and Antibiofilm Activity against Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 52, 2870, 10.1128/aac.00203-08 · DOI · Paper page
- Heir, 1999, The qacG Gene on Plasmid pST94 Confers Resistance to Quaternary Ammonium Compounds in Staphylococci Isolated from the Food Industry, J. Appl. Microbiol., 86, 378, 10.1046/j.1365-2672.1999.00672.x · DOI
- Herrera, 2019, First Report of Polymyxin B Activity in Klebsiella pneumoniae Biofilm, J. Chemother., 31, 127, 10.1080/1120009x.2018.1558751 · DOI
- Herruzo, 2020, Antimicrobial Efficacy of a Very Stable Hypochlorous Acid Formula Compared with Other Antiseptics Used in Treating Wounds: In-Vitro Study on Micro-organisms with or without Biofilm, J. Hosp. Infect., 105, 289, 10.1016/j.jhin.2020.01.013 · DOI
- Hill, 2000, The In-Vitro Activity of Povidone–Iodine Cream against Staphylococcus aureus and its Bioavailability in Nasal Secretions, J. Hosp. Infect., 45, 198, 10.1053/jhin.2000.0733 · DOI
- Hoekstra, 2017, Povidone‐iodine Ointment Demonstrates In Vitro Efficacy against Biofilm Formation, Int. Wound J., 14, 172, 10.1111/iwj.12578 · DOI
- Hogan, 2016, In Vitro approach for Identification of the Most Effective Agents for Antimicrobial Lock Therapy in the Treatment of Intravascular Catheter-Related Infections Caused by Staphylococcus aureus, Antimicrob. Agents Chemother., 60, 2923, 10.1128/aac.02885-15 · DOI
- Hoggard, Evidence of Microbiota Dysbiosis in Chronic Rhinosinusitis, Int. Forum Allergy Rhinol, 7, 230, 10.1002/alr.21871 · DOI · Paper page
- Hoggard, Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease, Clin. Microbiol. Rev., 30, 321, 10.1128/cmr.00060-16 · DOI
- Hoggard, 2019, The Sinonasal Mycobiota in Chronic Rhinosinusitis and Control Patients, Rhinology, 57, 190, 10.4193/rhin18.256 · DOI
- Horner, 2012, Reduced Susceptibility to Chlorhexidine in Staphylococci: Is it Increasing and Does it Matter?, J. Antimicrob. Chemother., 67, 2547, 10.1093/jac/dks284 · DOI · Paper page
- Isaacs, 2011, The Effect of Dilute Baby Shampoo on Nasal Mucociliary Clearance in Healthy Subjects, Am. J. Rhinol Allergy, 25, e27, 10.2500/ajra.2011.25.3583 · DOI
- Jain, 2015, The Effects of Topical Agents on Paranasal Sinus Mucosa Healing: a Rabbit Study, Int. Forum Allergy Rhinol, 5, 310, 10.1002/alr.21470 · DOI
- Jain, 2016, The In Vitro Effect of Xylitol on Chronic Rhinosinusitis Biofilms, Rhinology, 54, 323, 10.4193/rhin15.380 · doi:10.4193/rhin15.380
- Jennings, 2014, Biofilm‐eradicating Properties of Quaternary Ammonium Amphiphiles: Simple Mimics of Antimicrobial Peptides, ChemBioChem, 15, 2211, 10.1002/cbic.201402254 · DOI
- Jeronimo, 2020, Effects of Povidone‐iodine Composite on the Elimination of Bacterial Biofilm, Int. Forum Allergy Rhinol, 10, 884, 10.1002/alr.22568 · doi:10.1002/alr.22568
- Jervis‐Bardy, 2011, Methylglyoxal‐infused Honey Mimics the Anti‐ Staphylococcus aureus Biofilm Activity of Manuka Honey: Potential Implication in Chronic Rhinosinusitis, Laryngoscope, 121, 1104, 10.1002/lary.21717 · DOI
- Johani, 2018, Evaluation of Short Exposure Times of Antimicrobial Wound Solutions against Microbial Biofilms: from In Vitro to In Vivo, J. Antimicrob. Chemother., 73, 494, 10.1093/jac/dkx391 · DOI
- Jorge, 2017, Searching for New Strategies against Biofilm Infections: Colistin-AMP Combinations against Pseudomonas aeruginosa and Staphylococcus aureus Single- and Double-Species Biofilms, PLoS ONE, 12, e0174654, 10.1371/journal.pone.0174654 · DOI
- Kamaruzzaman, 2017, Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine Mastitis, Front. Microbiol., 8, 1518, 10.3389/fmicb.2017.01518 · DOI
- Kang, 2019, Antimicrobial Peptide LL-37 Is Bactericidal against Staphylococcus aureus Biofilms, PLoS ONE, 14, e0216676, 10.1371/journal.pone.0216676 · DOI
- Karas, 2020, The Antimicrobial Activity of Cannabinoids, Antibiotics, 9, 406, 10.3390/antibiotics9070406 · DOI
- Khondker, 2020, How Do Bacterial Membranes Resist Polymyxin Antibiotics?, Commun. Biol., 3, 77, 10.1038/s42003-020-0803-x · DOI
- Kilty, 2010, Manuka Honey: Histological Effect on Respiratory Mucosa, Am. J. Rhinol Allergy, 24, e63, 10.2500/ajra.2010.24.345310.2500/194589210791496519 · doi:10.2500/ajra.2010.24.345310.2500/194589210791496519
- Kilty, 2011, Methylglyoxal: (Active Agent of Manuka Honey) In Vitro Activity against Bacterial Biofilms, Int. Forum Allergy Rhinol, 1, 348, 10.1002/alr.20073 · DOI
- Kim, 2015, Betadine Has a Ciliotoxic Effect on Ciliated Human Respiratory Cells, J. Laryngol. Otol, 129, S45, 10.1017/s0022215114002746 · doi:10.1017/s0022215114002746
- Klinger-Strobel, 2017, Effects of Colistin on Biofilm Matrices of Escherichia coli and Staphylococcus aureus, Int. J. Antimicrob. Agents, 49, 472, 10.1016/j.ijantimicag.2017.01.005 · DOI
- Ko, 2018, In Vitro antibacterial Effects of Statins against Bacterial Pathogens Causing Skin Infections, Eur. J. Clin. Microbiol. Infect. Dis., 37, 1125, 10.1007/s10096-018-3227-5 · DOI
- Kolpen, 2016, Increased Bactericidal Activity of Colistin on Pseudomonas aeruginosa Biofilms in Anaerobic Conditions, Pathog. Dis., 74, ftv086, 10.1093/femspd/ftv086 · DOI
- Krasowski, 2021, In Vitro evaluation of Polihexanide, Octenidine and NaClO/HClO-Based Antiseptics against Biofilm Formed by Wound Pathogens, Membranes, 11, 62, 10.3390/membranes11010062 · DOI
- Lee, 2017, Manuka Honey Sinus Irrigation for the Treatment of Chronic Rhinosinusitis: a Randomized Controlled Trial, Int. Forum Allergy Rhinol, 7, 365, 10.1002/alr.21898 · doi:10.1002/alr.21898
- Lefebvre, 2016, Synergistic Antibiofilm Efficacy of Various Commercial Antiseptics, Enzymes and EDTA: a Study of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms, Int. J. Antimicrob. Agents, 48, 181, 10.1016/j.ijantimicag.2016.05.008 · DOI
- Lima, 2019, Evaluation of the Interaction between Polymyxin B and Pseudomonas aeruginosa Biofilm and Planktonic Cells: Reactive Oxygen Species Induction and Zeta Potential, BMC Microbiol., 19, 115, 10.1186/s12866-019-1485-8 · DOI
- Lin, 2017, Xylitol Nasal Irrigation in the Treatment of Chronic Rhinosinusitis, Am. J. Otolaryngol., 38, 383, 10.1016/j.amjoto.2017.03.006 · DOI
- Liu, 2018, Tetrasodium EDTA Is Effective at Eradicating Biolms Formed by Clinically Relevant Microorganisms from Patients’ central Venous Catheters, mSphere, 3, e00525, 10.1128/msphere.00525-18 · DOI
- Liu, 2017, In Vitro and In Vivo Activity of EDTA and Antibacterial Agents against the Biofilm of Mucoid Pseudomonas aeruginosa, Infection, 45, 23, 10.1007/s15010-016-0905-z · DOI
- Lux, 2022, The In Vitro Efficacy of Neutral Electrolysed Water and Povidone-Iodine against CRS-Associated Biofilms, Rhinology, 60, 73, 10.4193/rhin21.301 · DOI
- Machuca, 2019, Comparative Activity of a Polyhexanide–Betaine Solution against Biofilms Produced by Multidrug-Resistant Bacteria Belonging to High-Risk Clones, J. Hosp. Infect., 103, e92, 10.1016/j.jhin.2019.04.008 · doi:10.1016/j.jhin.2019.04.008
- Mills, 1956, Staphylococcus Bacteriophage Lysate Aerosol Therapy of Sinusitis, Laryngoscope, 66, 846, 10.1288/00005537-195607000-00004 · doi:10.1288/00005537-195607000-00004
- Müller, 2008, Biocompatibility index of Antiseptic Agents by Parallel Assessment of Antimicrobial Activity and Cellular Cytotoxicity, J. Antimicrob. Chemother., 61, 1281, 10.1093/jac/dkn125 · DOI · Paper page
- Ooi, Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus, JAMA Otolaryngol. Head Neck Surg., 145, 723, 10.1001/jamaoto.2019.1191 · DOI · Paper page
- Ooi, Manuka Honey Sinus Irrigations in Recalcitrant Chronic Rhinosinusitis: Phase 1 Randomized, Single‐blinded, Placebo‐controlled Trial, Int. Forum Allergy Rhinol, 9, 1470, 10.1002/alr.22423 · doi:10.1002/alr.22423
- Ooi, Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis, Front. Microbiol., 9, 720, 10.3389/fmicb.2018.00720 · DOI · Paper page
- Ooi, Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model, Front. Microbiol., 9, 917, 10.3389/fmicb.2018.00917 · DOI
- Orlandi, 2021, International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021, Int. Forum Allergy Rhinol, 11, 213, 10.1002/alr.22741 · DOI · Paper page
- Panchmatia, 2019, The Efficacy of Diluted Topical Povidone-Iodine Rinses in the Management of Recalcitrant Chronic Rhinosinusitis: a Prospective Cohort Study, Eur. Arch. Otorhinolaryngol., 276, 3373, 10.1007/s00405-019-05628-w · DOI
- Papa, 2020, Safety and Tolerability of Topical Polyhexamethylene Biguanide: a Randomised Clinical Trial in Healthy Adult Volunteers, Br. J. Ophthalmol., 106, 190, 10.1136/bjophthalmol-2020-317848 · doi:10.1136/bjophthalmol-2020-317848
- Paramasivan, 2014, Methylglyoxal‐augmented Manuka Honey as a Topical Anti– Staphylococcus aureus Biofilm Agent: Safety and Efficacy in an In Vivo Model, Int. Forum Allergy Rhinol, 4, 187, 10.1002/alr.21264 · DOI
- Percival, 2017, The Efficacy of Tetrasodium EDTA on Biofilms, 101
- Premkumar, 2021, Comparing the Efficacy of Irrigation Solutions on Staphylococcal Biofilm Formed on Arthroplasty Surfaces, J. Arthroplasty, 36, S26, 10.1016/j.arth.2021.02.033 · doi:10.1016/j.arth.2021.02.033
- Psaltis, 2008, Reduced Levels of Lactoferrin in Biofilm-Associated Chronic Rhinosinusitis, Laryngoscope, 118, 895, 10.1097/mlg.0b013e31816381d4 · DOI
- Ramamourthy, 2021, Antibiofilm Activity of Lactoferrin-Derived Synthetic Peptides against Pseudomonas aeruginosa PAO1, Biochem. Cel Biol, 99, 138, 10.1139/bcb-2020-0253 · DOI
- Ramezanpour, 2020, In Vitro safety Evaluation of a Povidone‐iodine Solution Applied to Human Nasal Epithelial Cells, Int. Forum Allergy Rhinol, 10, 1141, 10.1002/alr.22575 · DOI
- Reimer, 2002, Antimicrobial Effectiveness of Povidone-Iodine and Consequences for New Application Areas, Dermatology, 204, 114, 10.1159/000057738 · doi:10.1159/000057738
- Richter, Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections, ACS Appl. Mater. Inter., 9, 21631, 10.1021/acsami.7b03672 · DOI
- Richter, 2016, Mind “De GaPP”: In Vitro Efficacy of Deferiprone and Gallium‐protoporphyrin against Staphylococcus aureus Biofilms, Int. Forum Allergy Rhinol, 6, 737, 10.1002/alr.21735 · DOI
- Richter, A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity, Antimicrob. Agents Chemother., 61, e00481, 10.1128/aac.00481-17 · DOI
- Riechelmann, 2004, Nasal Toxicity of Benzalkonium Chloride, Am. J. Rhinol, 18, 291, 10.1177/194589240401800506 · DOI
- Röhner, 2020, Sodium Hypochlorite Is More Effective Than Chlorhexidine for Eradication of Bacterial Biofilm of Staphylococci and Pseudomonas aeruginosa, Knee Surg. Sports Traumatol. Arthrosc., 28, 3912, 10.1007/s00167-020-05887-9 · DOI
- Roy, 2018, Strategies for Combating Bacterial Biofilms: a Focus on Anti-biofilm Agents and Their Mechanisms of Action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
- Rudilla, 2018, Novel Synthetic Polymyxins Kill Gram-Positive Bacteria, J. Antimicrob. Chemother., 73, 3385, 10.1093/jac/dky366 · doi:10.1093/jac/dky366
- Sahariah, 2018, Quaternary Ammoniumyl Chitosan Derivatives for Eradication of Staphylococcus aureus Biofilms, Biomacromolecules, 19, 3649, 10.1021/acs.biomac.8b00718 · doi:10.1021/acs.biomac.8b00718
- Scheper, 2021, SAAP-148 Eradicates MRSA Persisters within Mature Biofilm Models Simulating Prosthetic Joint Infection, Front. Microbiol., 12, 625952, 10.3389/fmicb.2021.625952 · DOI
- Schreier, 1997, Molecular Effects of Povidone-Iodine on Relevant Microorganisms: an Electron-Microscopic and Biochemical Study, Dermatology, 195, 111, 10.1159/000246043 · doi:10.1159/000246043
- Shelanski, 1956, PVP-iodine: History, Toxicity and Therapeutic Uses, J. Int. Coll. Surg., 25, 727
- Singhal, 2011, Staphylococcus aureus Biofilms: Nemesis of Endoscopic Sinus Surgery, Laryngoscope, 121, 1578, 10.1002/lary.21805 · DOI
- Siu, 2020, Oral Antibiotics Used in the Treatment of Chronic Rhinosinusitis Have Limited Penetration into the Sinonasal Mucosa: a Randomized Trial, Xenobiotica, 50, 1443, 10.1080/00498254.2020.1814973 · DOI · Paper page
- Sivaranjani, 2021, Synergistic Activity of Tetrasodium EDTA, Ethanol and Chlorhexidine Hydrochloride against Planktonic and Biofilm Cells of Clinically Relevant Pathogens, J. Glob. Antimicrob. Resist., 24, 148, 10.1016/j.jgar.2020.12.002 · DOI
- Stewart, 2001, Antibiotic Resistance of Bacteria in Biofilms, Lancet, 358, 135, 10.1016/s0140-6736(01)05321-1 · DOI · Paper page
- Su, 2019, Polymyxin Derivatives as Broad-Spectrum Antibiotic Agents, Chem. Commun., 55, 13104, 10.1039/c9cc06908a · doi:10.1039/c9cc06908a
- Sultan, 2017, Chelation Therapy in Cardiovascular Disease: an Update, Expert Rev. Clin. Pharmacol., 10, 843, 10.1080/17512433.2017.1339601 · DOI
- Taylor, 2021, Non-steroid, Non-antibiotic Anti-biofilm Therapy for the Treatment of Chronic Rhinosinusitis: a Systematic Review, J. Laryngol. Otol, 135, 196, 10.1017/s0022215121000542 · DOI
- Thangamani, 2015, Exploring Simvastatin, an Antihyperlipidemic Drug, as a Potential Topical Antibacterial Agent, Sci. Rep., 5, 16407, 10.1038/srep16407 · DOI
- Thieme, 2019, MBEC versus MBIC: the Lack of Differentiation between Biofilm Reducing and Inhibitory Effects as a Current Problem in Biofilm Methodology, Biol. Proced. Online, 21, 18, 10.1186/s12575-019-0106-0 · DOI
- Thorn, 2012, Electrochemically Activated Solutions: Evidence for Antimicrobial Efficacy and Applications in Healthcare Environments, Eur. J. Clin. Microbiol. Infect. Dis., 31, 641, 10.1007/s10096-011-1369-9 · DOI
- Turner, 2017, Safety and Tolerability of Surfactant Nasal Irrigation, Int. Forum Allergy Rhinol, 7, 809, 10.1002/alr.21959 · doi:10.1002/alr.21959
- Valentine, 2011, Efficacy of Using a Hydrodebrider and of Citric Acid/zwitterionic Surfactant on a Staphylococcus aureus Bacterial Biofilm in the Sheep Model of Rhinosinusitis, Am. J. Rhinol Allergy, 25, 323, 10.2500/ajra.2011.25.3659 · DOI
- van de Donk, 1980, The Effects of Preservatives on the Ciliary Beat Frequency of Chicken Embryo Tracheas, Rhinology, 18, 119
- van Klingeren, 1976, Antibacterial Activity of Δ9-tetrahydrocannabinol and Cannabidiol, Antonie van Leeuwenhoek, 42, 9, 10.1007/BF00399444 · DOI
- Verderosa, 2019, Bacterial Biofilm Eradication Agents: a Current Review, Front. Chem., 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
- Vickery, 2019, The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis, Curr. Allergy Asthma Rep., 19, 21, 10.1007/s11882-019-0853-7 · DOI
- Wagner Mackenzie, 2017, Bacterial Community Collapse: a Meta‐analysis of the Sinonasal Microbiota in Chronic Rhinosinusitis, Environ. Microbiol., 19, 381, 10.1111/1462-2920.13632 · DOI · Paper page
- Wagner Mackenzie, 2020, A Novel Description of the Human Sinus Archaeome during Health and Chronic Rhinosinusitis, Front. Cel Infect Microbiol, 10, 398, 10.3389/fcimb.2020.00398 · DOI
- Weissman, 2011, Xylitol Nasal Irrigation in the Management of Chronic Rhinosinusitis: a Pilot Study, Laryngoscope, 121, 2468, 10.1002/lary.22176 · DOI
- Wu, 2021, Efficacy of Povidone‐iodine Nasal Irrigation Solution after Sinonasal Surgery: a Randomized Controlled Study, Laryngoscope, 1, 1, 10.1002/lary.29818 · doi:10.1002/lary.29818
- Yin, 2020, Mechanisms of Bactericidal Action and Resistance of Polymyxins for Gram-Positive Bacteria, Appl. Microbiol. Biotechnol., 104, 3771, 10.1007/s00253-020-10525-y · DOI
- Yoshida, 1993, Potent In Vitro Bactericidal Activity of Polymyxin B against Methicillin‐resistant Staphylococcus aureus (MRSA), Microbiol. Immunol., 37, 853, 10.1111/j.1348-0421.1993.tb01716.x · DOI
- Zheng, 2021, Effect of Polyhexamethylene Biguanide in Combination with Undecylenamidopropyl Betaine or PslG on Biofilm Clearance, Int. J. Mol. Sci., 22, 768, 10.3390/ijms22020768 · DOI
Cited by
Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102426 · Cited by 20
Metadata
- Authors
- Hale, S. J. M., Wagner Mackenzie, B., Lux, C. A., Biswas, K., Kim, R., & Douglas, R. G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-13
- Volume
- 13
- ISSN
- 1663-9812
- Cited by
- 13
- References
- 1
- Funders
- Garnett Passe and Rodney Williams Memorial Foundation (3719672 3723406)
- Auckland Medical Research Foundation (3721397)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review. https://app.cochat.ai/papers/10.3389/fphar.2022.840323
- The paper
- Hale, S. J. M., Wagner Mackenzie, B., Lux, C. A., Biswas, K., Kim, R., & Douglas, R. G. (2022). Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.840323
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.